Detalles de la búsqueda
1.
Performance of idarucizumab as antidote of dabigatran in daily clinical practice.
Europace
; 21(3): 414-420, 2019 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30339226
2.
Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study.
Europace
; 16(10): 1417-25, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24938627
3.
Heparin-induced thrombocytopenia after ICD-lead flushing.
Acta Cardiol
; 69(2): 197-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24783473
4.
Lenient versus strict rate control in patients with atrial fibrillation.
N Engl J Med
; 362(15): 1363-73, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20231232
5.
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
Am Heart J
; 152(3): 420-6, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16923407
6.
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial.
Heart
; 99(19): 1421-30, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23813851
7.
Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
Circ Arrhythm Electrophysiol
; 5(4): 748-56, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22787013
8.
The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
J Am Coll Cardiol
; 58(17): 1795-803, 2011 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21996393
Resultados
1 -
8
de 8
1
Próxima >
>>